JOHN M. BAILEY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Theriva Biologics, Inc.

Filing Date Source Excerpt
2001-04-06 John M. Bailey 53 April 1997 Director ... The Stock Option Committee reviews, analyzes and approves grants of stock options and stock to eligible persons under the Company's 1993 Stock Option Plan and the Company's 1993 Restricted Stock Plan. The current members of the Stock Option Committee (appointed in June 1997) are Digby W. Barrios and John M. Bailey. ... The Compensation Committee reviews, analyses and makes recommendations to the Board of Directors regarding compensation of Company directors, employees, consultants and others, including grants of stock options (other than stock option grants under the Company's 1993 Stock Option Plan and the Company's 1996 Directors Stock Option Plan). The current members of the Compensation Committee (appointed in June 1997) are Digby W. Barrios and John M. Bailey. ... The Company has an Audit Committee composed of independent directors, ... The current independent directors of the Audit Committee are Digby W. Barrios, John M. Bailey, (both appointed in June 1997) and Todd C. Davis (appointed May 2000).
2002-04-30 John M. Bailey. Mr. Bailey has been a Director of the Company since April 1997 and has served as Chairman of the Company since April 2002. ... The current members of the Stock Option Committee (appointed in June 1997) are Digby W. Barrios and John M. Bailey. ... The current members of the Compensation Committee (appointed in June 1997) are Digby W. Barrios and John M. Bailey. ... The current independent directors of the Audit Committee are Digby W. Barrios, John M. Bailey (both appointed in June 1997), and Todd C. Davis.

Data sourced from SEC filings. Last updated: 2026-02-03